Dexamethasone Regulates EphA5, a Potential Inhibitory Factor with Osteogenic Capability of Human Bone Marrow Stromal Cells
We previously demonstrated the importance of quality management procedures for the handling of human bone marrow stromal cells (hBMSCs) and provided evidence for the existence of osteogenic inhibitor molecules in BMSCs. One candidate inhibitor is the ephrin type-A receptor 5 (EphA5), which is expres...
Saved in:
Main Authors: | Tsuyoshi Yamada (Author), Toshitaka Yoshii (Author), Hiroaki Yasuda (Author), Atsushi Okawa (Author), Shinichi Sotome (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
by: Theodore J. Kottom, et al.
Published: (2024) -
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
by: Ahmed F. Salem, et al.
Published: (2020) -
COMPLEMENTARY EXPRESSION OF EphA7 AND SCO-SPONDIN DURING POSTERIOR COMMISSURE DEVELOPMENT
by: Karen eStanic, et al.
Published: (2014) -
Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic
by: Walid Kamoun, et al.
Published: (2020) -
EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cord
by: Shih-Pei Shen, et al.
Published: (2015)